Investigator Initiated Pilot Study of Microarray Directed Therapy for Diffuse Large B-Cell Lymphoma Using Genasense With CHOP-R.
Phase of Trial: Phase II
Latest Information Update: 12 Oct 2012
At a glance
- Drugs Cyclophosphamide; Doxorubicin; Oblimersen; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 12 Oct 2012 Planned End Date changed from 1 Dec 2013 to 1 Oct 2022 as reported by ClinicalTrials.gov record.
- 12 Oct 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 02 Jun 2010 Additional trial centre, investigator identified as reported by ClinicalTrials.gov.